50
Participants
Start Date
January 15, 2021
Primary Completion Date
June 2, 2021
Study Completion Date
February 9, 2022
standard-of-care clinical skin examination
inspection of melanocytic nevi by dermatologist
skin assessment with the 2D FotoFinder ATBM master system
The FotoFinder® ATBM master device provides the combination of total body mapping with deep learning-driven body scan algorithm which identifies all pigmented skin lesions of the body surface by pattern recognition software and supplies a risk assessment score (0.0-1.0; 0 indicating no suspicion for melanoma, 1 indicating a high suspicion for melanoma).The integrated software analyzer scores regarding malignancy probability of the moles (FotoFinder® score: 0.0-1.0) will be collected.
data collection by participant questionnaire
At baseline, the participants will complete a questionnaire concerning their previous exposure to sun, their current sun-related protective behaviours, their history of skin check frequency and skin cancer at baseline. Additionally, in each consultation newly-created study-specific questions concerning the participants' examination experience, the sun-related protective behaviours and worries about skin cancer throughout the study will be investigated.
University Hospital Basel, Department of Dermatology, Basel
University Hospital, Basel, Switzerland
OTHER